IFNG and tuberculosis: Together, our in vitro and in vivo results suggest that in hypercholesterolemic patients receiving statin therapy, these drugs could help FMs to activate an efficient IFNγ/cytotoxic response that controls the pathogen at the earliest stages of infection, thus preventing their conversion to LL-FMs and the development of active tuberculosis.